Leader of the Dentons Cannabis Group Eric Berlin was quoted in Law360 in a recent article covering the evolving federal regulatory landscape for the medical marijuana industry following the DOJ's rescheduling of state-sanctioned medical marijuana to Schedule III, including the DEA's new registration process, open questions around Section 280E tax relief, and ongoing coordination between federal and state regulators.